Full Text View
Tabular View
No Study Results Posted
Related Studies
Atazanavir for HIV Infected Individuals: An Early Access Program
Expanded access is no longer available for this treatment.
First Received: September 26, 2002   Last Updated: June 27, 2008   History of Changes
Sponsor: Bristol-Myers Squibb
Information provided by: Bristol-Myers Squibb
ClinicalTrials.gov Identifier: NCT00046345
  Purpose

The purpose of this clinical research study is to provide atazanavir to patients infected with human immunodeficiency virus (HIV) whose antiviral medications are no longer working to control HIV activity within the body and who are unable to create a new treatment regimen using other available anti-HIV drugs, because of either side effects or treatment failure previously taken. The safety of this treatment will also be studied.


Condition Intervention
HIV Infections
 Drug: Atazanavir (BMS-232632)

Study Type: Expanded Access

Resource links provided by NLM:

MedlinePlus related topics: AIDS
Drug Information available for: BMS 232632 Atazanavir sulfate
U.S. FDA Resources

Further study details as provided by Bristol-Myers Squibb:

Study Start Date: May 2002
Estimated Study Completion Date: July 2003
  Eligibility

Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Key inclusion criteria:

  • Patients eligible for inclusion into the EAP are those that are a virologic failure due to resistance, intolerance and/or adherence problems with current anti-HIV medications;
  • OR have multiple toxicities or intolerance to their anti-HIV medication but are not a virologic failure;
  • OR have severe elevated lipids in the blood (e.g., cholesterol, triglycerides) that do not respond to lipid-lowering medication.

Key exclusion Criteria:

  • Restrictions apply regarding the use of atazanavir with specific medications which may have a potential to cause possible side effects when taken together.
  • Patients will also be excluded for any of the following reasons: 1) pregnancy or breast feeding, 2) elevated liver enzymes, 3) significant cardiovascular disease, or 4) other restrictions as indicated in the protocol.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00046345

  Hide Study Locations
Locations
United States, Alabama
Local Institution
Hobson City, Alabama, United States, 36201
United States, Alaska
Local Institution
Anchorage, Alaska, United States, 99508
United States, Arizona
Local Institution
Phoenix, Arizona, United States
Local Institution
Scottsdale, Arizona, United States
Local Institution
Tucson, Arizona, United States
United States, Arkansas
Local Institution
Little Rock, Arkansas, United States
United States, California
Local Institution
Fountain Valley, California, United States, 92708
Local Institution
Los Angeles, California, United States, 90022
Local Institution
Beverly Hills, California, United States
Local Institution
Harbor City, California, United States
Local Institution
San Diego, California, United States
Local Institution
Long Beach, California, United States
Local Institution
Glendale, California, United States
Local Institution
West Hills, California, United States
Local Institution
Tarzana, California, United States
Local Institution
Woodland Hills, California, United States
Local Institution
Panorama City, California, United States
Local Institution
Sherman Oaks, California, United States
Local Institution
El Cajon, California, United States
Local Institution
Paramount, California, United States
Local Institution
Palm Springs, California, United States
Local Institution
Fontana, California, United States
Local Institution
San Bernardino, California, United States
Local Institution
Newport Beach, California, United States
Local Institution
Santa Ana, California, United States
Local Institution
Bakersfield, California, United States
Local Institution
San Mateo, California, United States
Local Institution
Sunnyvale, California, United States
Local Institution
San Francisco, California, United States
Local Institution
Palo Alto, California, United States
Local Institution
Lancaster, California, United States
Local Institution
Fairfield, California, United States
Local Institution
Oakland, California, United States
Local Institution
Berkeley, California, United States
Local Institution
San Rafael, California, United States
Local Institution
Mill Valley, California, United States
Local Institution
San Jose, California, United States
Local Institution
Santa Rosa, California, United States
Local Institution
Sacramento, California, United States
United States, Colorado
Local Institution
Denver, Colorado, United States, 80204
Local Institution
Wheat Ridge, Colorado, United States
United States, Connecticut
Local Institution
Rockville, Connecticut, United States
Local Institution
Hartford, Connecticut, United States
Local Institution
Meriden, Connecticut, United States
Local Institution
Norwalk, Connecticut, United States
United States, District of Columbia
Local Institution
Washington, District of Columbia, United States
United States, Florida
Local Institution
Gainesville, Florida, United States, 32608
Local Institution
Daytona Beach, Florida, United States
Local Institution
Jacksonville, Florida, United States
Local Institution
Pensacola, Florida, United States
Local Institution
Altamonte Springs, Florida, United States
Local Institution
Winter Park, Florida, United States
Local Institution
Oakland Park, Florida, United States
Local Institution
Hollywood, Florida, United States
Local Institution
Key West, Florida, United States
Local Institution
Pompano Beach, Florida, United States
Local Institution
Miami, Florida, United States
Local Institution
Miami Beach, Florida, United States
Local Institution
North Miami Beach, Florida, United States
Local Institution
Fort Lauderdale, Florida, United States
Local Institution
Plantation, Florida, United States
Local Institution
Vero Beach, Florida, United States
Local Institution
North Palm Beach, Florida, United States
Local Institution
Tampa, Florida, United States
Local Institution
Bay Pines, Florida, United States
Local Institution
Winter Haven, Florida, United States
Local Institution
Fort Myers, Florida, United States
Local Institution
Bradenton, Florida, United States
LOcal Instituton
Sarasota, Florida, United States
United States, Georgia
Local Institution
Decatur, Georgia, United States
Local Institution
Tucker, Georgia, United States
Local Institution
Atlanta, Georgia, United States
Local Institution
Macon, Georgia, United States
Local Institution
Jesup, Georgia, United States
United States, Hawaii
Local Institution
Kahului, Hawaii, United States
Local Institution
Honolulu, Hawaii, United States
United States, Illinois
Local Institution
Chicago, Illinois, United States, 60610
Local Institution
Joliet, Illinois, United States
Local Institution
Chicago, Illinois, United States
Local Institution
Springfield, Illinois, United States
United States, Indiana
Local Institution
Munster, Indiana, United States
Local Institution
Evansville, Indiana, United States
United States, Kansas
Local Institution
Kansas City, Kansas, United States
Local Institution
Topeka, Kansas, United States
United States, Kentucky
Local Institution
Paducah, Kentucky, United States
United States, Louisiana
Local Institution
New Orleans, Louisiana, United States
United States, Maine
Local Institution
Portland, Maine, United States
United States, Maryland
Local Institution
Baltimore, Maryland, United States
Local Institution
Bethesda, Maryland, United States
United States, Massachusetts
Local Institution
Springfield, Massachusetts, United States
Local Institution
Boston, Massachusetts, United States
Local Institution
Hyannis, Massachusetts, United States
Local Institution
Provincetown, Massachusetts, United States
United States, Michigan
Local Institution
Berkley, Michigan, United States
Local Institution
Grand Rapids, Michigan, United States
United States, Minnesota
Local Institution
Minneapolis, Minnesota, United States
Local Institution
Rochester, Minnesota, United States
United States, Missouri
Local Institution
Kansas City, Missouri, United States, 64111
Local Institution
St. Louis, Missouri, United States
United States, Nevada
Local Institution
Las Vegas, Nevada, United States
Local Institution
Reno, Nevada, United States
United States, New Jersey
Local Institution
Hoboken, New Jersey, United States
Local Institution
West Orange, New Jersey, United States
Local Institution
Union, New Jersey, United States
Local Instituton
Westfield, New Jersey, United States
Local Institution
Newark, New Jersey, United States
Local Institution
Elizabeth, New Jersey, United States
Local Institution
Hackensack, New Jersey, United States
Local Institution
Englewood, New Jersey, United States
Local Institution
Neptune, New Jersey, United States
Local Institution
Voorhees, New Jersey, United States
Local Institution
Camden, New Jersey, United States
United States, New Mexico
Local Institution
Albuquerque, New Mexico, United States
Local Institution
Santa Fe, New Mexico, United States
United States, New York
Local Institution
New York, New York, United States
Local Institution
Bronx, New York, United States
Local Institution
Mount Vernon, New York, United States
Local Institution
Valhalla, New York, United States
Local Institution
New Hyde Park, New York, United States
Local Institution
Brooklyn, New York, United States
Local Institution
Southampton, New York, United States
Local Institution
Rochester, New York, United States
Local Institution
Elmira, New York, United States
United States, North Carolina
Local Institution
Winston-Salem, North Carolina, United States
Local Institution
Greenville, North Carolina, United States
Local Institution
Washington, North Carolina, United States
Local Institution
Huntersville, North Carolina, United States
Local Institution
Charlotte, North Carolina, United States
Local Institution
Asheville, North Carolina, United States
United States, Ohio
Local Institution
Akron, Ohio, United States, 44302
Local Institution
Columbus, Ohio, United States
Local Institution
Cleveland, Ohio, United States
United States, Oregon
Local Institution
Portland, Oregon, United States, 97201-3098
United States, Pennsylvania
Local Institution
York, Pennsylvania, United States
Local Institution
Lancaster, Pennsylvania, United States
Local Institution
Allentown, Pennsylvania, United States
Local Institution
Philadelphia, Pennsylvania, United States
Local Institution
West Reading, Pennsylvania, United States
United States, Rhode Island
Local Institution
Providence, Rhode Island, United States
United States, South Carolina
Local Institution
Columbia, South Carolina, United States
United States, Tennessee
Local Institution
Nashville, Tennessee, United States
Local Institution
Knoxville, Tennessee, United States
United States, Texas
Local Institution
Dallas, Texas, United States, 75205
Local Institution
Fort Worth, Texas, United States, 76104
Local Institution
Tyler, Texas, United States, 75701
Local Institution
Houston, Texas, United States
Local Institution
San Antonio, Texas, United States
Local Institution
Corpus Christi, Texas, United States
Local Institution
Harlingen, Texas, United States
Local Institution
Austin, Texas, United States
Local Institution
El Paso, Texas, United States
United States, Virginia
local Institution
Fairfax, Virginia, United States
Local Institution
Richmond, Virginia, United States
Local Institution
Norfolk, Virginia, United States
Local Institution
Newport News, Virginia, United States
Local Institution
Roanoke, Virginia, United States
United States, Washington
Local Institution
Seattle, Washington, United States
Local Institution
Olympia, Washington, United States
Local Institution
Spokane, Washington, United States
United States, Wisconsin
Local Institution
Madison, Wisconsin, United States, 53792
Local Institution
Milwaukee, Wisconsin, United States
Local Institution
Madison, Wisconsin, United States
Local Institution
La Crosse, Wisconsin, United States
Puerto Rico
Local Institution
Ponce, Puerto Rico
Local Institution
Rio Piedras, Puerto Rico
Sponsors and Collaborators
Bristol-Myers Squibb
  More Information

Additional Information:
BMS Clinical Trials Disclosure  This link exits the ClinicalTrials.gov site
For FDA Safety Alerts and Recalls refer to the following link www.fda.gov/MEDWATCH/safety.htm  This link exits the ClinicalTrials.gov site

No publications provided

Study ID Numbers: AI424-900
Study First Received: September 26, 2002
Last Updated: June 27, 2008
ClinicalTrials.gov Identifier: NCT00046345     History of Changes
Health Authority: United States: Food and Drug Administration

Keywords provided by Bristol-Myers Squibb:
treatment experienced

Additional relevant MeSH terms:
Anti-Infective Agents
HIV Protease Inhibitors
RNA Virus Infections
Sexually Transmitted Diseases, Viral
Anti-HIV Agents
Slow Virus Diseases
Molecular Mechanisms of Pharmacological Action
Immune System Diseases
Acquired Immunodeficiency Syndrome
Enzyme Inhibitors
Atazanavir
Infection
 Antiviral Agents
Pharmacologic Actions
Immunologic Deficiency Syndromes
Protease Inhibitors
Virus Diseases
Anti-Retroviral Agents
HIV Infections
Therapeutic Uses
Sexually Transmitted Diseases
Lentivirus Infections
Retroviridae Infections

ClinicalTrials.gov processed this record on November 27, 2009



Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services